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ABSTRACT
The location of osteoporotic fragility fractures adds crucial information to post-fracture risk estimation. Triaging patients according to
fracture site for secondary fracture prevention can therefore be of interest to prioritize patients considering the high imminent fracture
risk. The objectives of this cross-sectional study were therefore to explore potential differences between central (vertebral, hip, proximal
humerus, pelvis) and peripheral (forearm, ankle, other) fractures. This substudy of the Norwegian Capture the Fracture Initiative
(NoFRACT) included 495 women and 119 men ≥50 years with fragility fractures. They had bone mineral density (BMD) of the femoral
neck, total hip, and lumbar spine assessed using dual-energy X-ray absorptiometry (DXA), trabecular bone score (TBS) calculated, con-
comitantly vertebral fracture assessment (VFA) with semiquantitative grading of vertebral fractures (SQ1–SQ3), and a questionnaire con-
cerning risk factors for fractures was answered. Patients with central fractures exhibited lower BMD of the femoral neck (765 versus
827 mg/cm2), total hip (800 versus 876 mg/cm2), and lumbar spine (1024 versus 1062 mg/cm2); lower mean TBS (1.24 versus 1.28);
and a higher proportion of SQ1-SQ3 fractures (52.0% versus 27.7%), SQ2–SQ3 fractures (36.8% versus 13.4%), and SQ3 fractures
(21.5% versus 2.2%) than patients with peripheral fractures (all p < 0.05). All analyses were adjusted for sex, age, and body mass index
(BMI); and the analyses of TBS and SQ1–SQ3 fracture prevalence was additionally adjusted for BMD). In conclusion, patients with central
fragility fractures revealed lower femoral neck BMD, lower TBS, and higher prevalence of vertebral fractures on VFA than the patients
with peripheral fractures. This suggests that patients with central fragility fractures exhibit more severe deterioration of bone structure,
translating into a higher risk of subsequent fragility fractures and therefore they should get the highest priority in secondary fracture
prevention, although attention to peripheral fractures should still not be diminished. © 2019 American Society for Bone and Mineral
Research. © 2019 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.
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Introduction
Fragility fracture is a growing issueworldwide due to longer lifeexpectancies in most populations.(1) The predominant sites of
fractures vary with age, and proposed explanations are changes in
fall tendency, fall mechanism, and differential loss of cortical and
trabecular bone at different stages of aging.(2,3) In clinical assess-
ment after a fragility fracture, the site of fracture adds important
information on future fracture risk. In general, a fragility fracture
doubles the risk of any subsequent fracture,(4) a hip fracture triples
the risk of another hip fracture, and a vertebral fracture increases
the risk of subsequent vertebral fracture four to seven times.(4,5)
The imminent risk of subsequent fracture is highest the first year
after a major osteoporotic fracture (vertebral, hip, distal forearm,
proximal humerus) and is more marked in advanced age.(6,7) This
constitutes awindowof opportunitywhere antiosteoporotic treat-
ment should be targeted promptly toward patients at highest risk.
The International Osteoporosis Foundation (IOF) recommends
assessment of all patients with fragility fractures.(8) Targeting strat-
egies to identify patients at highest risk are warranted to give ade-
quate and timely post-fracture assessment to this large volume of
patients. Triaging patients according to fracture types associated
with higher or lower expected risk of subsequent fracture could
be convenient, especially in areas with limited resources. The
major osteoporotic fractures occur at sites that differ with respect
to amount and distribution of cortical and trabecular bone. In our
Fracture Liaison Service (FLS) clinics, we have observed that
patients with fractures at central sites, with abundant trabecular
bone (vertebral, hip, proximal humerus, and pelvis), seem to be
older and exhibit more pathological features on bone mineral
density (BMD), trabecular bone score (TBS), and vertebral fracture
assessment (VFA) than patients with fractures at peripheral sites
with relatively more cortical bone (forearm, ankle, and other
peripheral fractures). This division into central and peripheral frac-
tures diverges from established classifications of fractures such as
axial (vertebral, chest, and pelvic) versus appendicular (upper and
lower limb) fractures and hip or vertebral versus nonhip nonver-
tebral fractures. If the clinical observed difference between central
andperipheral fractures is significant andpersists after adjustment
for age and other confounders, this could help to select patients
with higher imminent risk of a subsequent fracture first and
patients at lower risk second in the FLS model of care.
The objectives of this study were to (i) investigate the risk fac-
tors for fractures including BMD, TBS, and proportion of vertebral
fracture using VFA in patients with different types of fragility frac-
tures, and (ii) explore the differences between central and
peripheral fractures, after adjustment for sex, age, body mass
index (BMI), and BMD.
Patients and Methods
Study subjects
NoFRACT is a multicenter study at seven hospitals in Norway
with 34976 patients enrolled by January 2019.(9) The objectives
of NoFRACT are to investigate the effect on the rate of subse-
quent fractures of introducing a standardized intervention pro-
gram consisting of an FLS model of care for identification,
assessment, and treatment of osteoporosis in patients with fra-
gility fractures. Eligible for the intervention were women and
men aged 50 years or older with any recently diagnosed fragility
fracture, except fractures in fingers, toes, and head.(9,10)
This cross-sectional substudy (ClinicalTrials.gov, NCT02608801)
of NoFRACT (ClinicalTrials.gov, NCT02536898) included patients
at the University Hospital of North Norway, Tromsø, from October
1, 2015, to December 31, 2017, and at the Drammen Hospital from
January 1, 2016, to December 31, 2017.(10) During this period, 2682
(>90%) patients above 50 years of age coming to the hospitals
with a fragility fracture were identified and offered fracture risk
assessment. In most of the elderly inpatients with fractures of
the hip, vertebrae, with two or more fragility fractures, or 10-year
probability of major osteoporotic fracture ≥20% calculated using
the Fracture Risk Assessment Tool (FRAX), the treatment decision
was assessed without a dual-energy X-ray absorptiometry (DXA)
scan (n= 1235). Participants in the substudywere recruited among
patients referred to DXA (n = 1447) as part of the post-fracture
assessment, of whom 58% provided written informed consent
(n = 839) and 789 had a DXA scan. Of the 789 with a DXA scan,
11 patients had no measurable hips because of metal implants,
and one patient was excluded because of poor image quality of
the DXA scan. Hence, 777 patients had valid BMD measurement
of at least one hip. Of the 785 patients with a DXA scan of the lum-
bar spine, eight patients were excluded because of less than two
evaluable vertebrae. Of the 730 patients who had TBS calculated,
26 patients were excluded due to BMI >37 kg/m2 (TBS values are
not recommended for use in patients with BMI >37 kg/m2
because of the influence of soft tissue) and 15 patients were
excluded because of fractures or anatomical aberrations in two
or more vertebrae. Further, only 679 of the patients had lateral
thoracolumbar scan for VFA performed. A total of 614 patients
had valid BMD measurements of the femoral neck and lumbar
spine, VFA, and TBS; 495 women and 119 men. No patients were
excluded because of causes known to affect bone metabolism,
such as chronic kidney disease (n = 22) or use of antiosteoporosis
drugs (n = 39). The study was approved by The Regional Commit-
tee for Medical and Health Research Ethics (REK 2014/2260).
To ensure data security a research platform for sensitive data
was used.
Variables
The index fractures leading to inclusion were as follows: hip frac-
tures (n = 41), vertebral fractures (thoracic and lumbar fractures)
(n = 32), proximal humerus fractures (n = 70), forearm fractures
(n = 247), ankle fractures (n = 117), and other fractures
(n = 107, including fractures of the pelvis, clavicle, humerus shaft,
elbow, hand, distal femur, patella, tibia, and foot). No patients
had rib or cervical fractures as index fracture. Vertebral fractures
that led to inclusion were diagnosed by X-ray, CT, or MRI, not by
VFA. Fracture cases were categorized into groups of index frac-
tures. Based on location and relative proportions of trabecular
and cortical bone, we chose to divide fractures into: central frac-
tures (vertebra, hip, proximal humerus, and pelvis) and periph-
eral fractures (humerus shaft, clavicle, elbow, forearm, hand,
distal femur, patella, tibia, ankle, and foot). We also divided the
patients into the established groups of axial (spine, chest, and
pelvic) versus appendicular (upper or lower limb) fractures. In
addition, information on number of previous fractures after the
age of 50 years, number of falls during the last 12 months before
inclusion, parental history of hip fractures, use of tobacco, diag-
nosis of rheumatoid arthritis, and use of glucocorticoids was col-
lected through a questionnaire.
Height and weight were measured. BMI was calculated as
weight (kg) per square meter height. BMD was measured at the
femoral neck and total hip bilaterally and lumbar spine (L1–L4)
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using DXA (Prodigy Pro; GE Lunar, Madison, WI, USA) in Tromsø
and iDXA (Prodigy Pro; GE Lunar, Madison, WI, USA) in Drammen.
Phantom quality assurance (QA) of the DXA equipment was per-
formed daily. Lumbar vertebrae with fracture were excluded.
BMD T-scores were calculated using the Third National Health
and Nutrition Examination Survey reference data for white
females aged 20 to 29 years.(11) Osteoporosis was defined as
femoral neck BMD T-score of−2.5 or less, and osteopenia as fem-
oral neck BMD T-score between −2.5 and −1.0 according to the
diagnosis criteria of the World Health Organization.(12)
TBS was calculated from the lumbar spine (L1–L4) DXA scans
using TBS iNsight™ software (Medimaps, Geneva, Switzerland)
version 3.0.1. Fractured vertebrae were omitted. The European
(Medimaps) reference population was used for both sexes. The
TBS values were divided into three groups according to esti-
mated fracture risk: high TBS ≥1.31 (low fracture risk), TBS
between 1.23 and 1.31 (intermediate fracture risk), and low
TBS ≤ 1.23 (high fracture risk).(13)
Images of the lateral thoracolumbar spine (T4–L4) were
obtained and VFA of the fracture severity was performed using
the semiquantitative (SQ) vertebral deformity scoring method
by Genant.(10,14) An SQ0 (<20% height loss) was considered as
a nonfractured vertebra, SQ1 (20% to 25% height loss) as a mild
fracture, SQ2 (25% to 40% height loss) as a moderate fracture,
and SQ3 (≥40% height loss) as a severe fracture. Presence of
one or more SQ1, SQ2, or SQ3 fractures was termed SQ1–SQ3
fracture and presence of one or more SQ2 or SQ3 fractures was
termed SQ2–SQ3 fracture. Patients were also categorized by
presence of at least one SQ3 fracture (yes versus no) as a mea-
sure of severe deteriorated microarchitecture in trabecular bone.
The interobserver agreement of SQ1–SQ3 fractures between two
experienced clinicians has shown a κ of 0.84 (95% confidence
interval, 0.70 to 0.98).(10)
Statistical analyses
The mean  SD for the continuous variables and n (%) for cate-
gorical variables of the characteristics are presented for each of
the fracture groups. Continuous variables were checked for nor-
mality using quantile-quantile (QQ) plot. The patients were strat-
ified by type of index fracture to show the proportion of patients
with osteoporosis at femoral neck, low TBS (TBS ≤ 1.23), and
SQ1–SQ3 in the fracture groups. Further, the patients were strat-
ified by age to show the distribution of osteoporosis, osteopenia,
and normal BMD at the femoral neck by age and type of fracture.
Scatterplot with regression lines of femoral neck BMD, TBS, and
proportion of vertebral fractures by 10-year age groups, and ver-
tical lines for themean age of patients with each type of fractures
are shown. Multiple linear regression analyses were used to
investigate differences in continuous variables between types
of fracture after adjustment for age and sex. Each group was
compared to the hip fracture group. This reference group was
chosen because fracture of the hip is considered the most seri-
ous. Differences between patients with central versus peripheral
fractures and axial versus appendicular fractures were assessed
using linear regression analyses for continuous variables and
Pearson chi-squared test or Fisher’s exact test for dichotomous
variables. The comparisons of risk factors for fracture between
the fracture groups are presented in three models: unadjusted;
after adjustment for sex, BMI, and femoral neck BMD; and after
an additional adjustment for age. In sensitivity analyses, we com-
pared central fractures versus forearm fractures, central fractures
versus peripheral fractures (after exclusion of other fractures),
and central (after exclusion of vertebral fractures) versus periph-
eral fractures, which are shown in Tables S1–S3. To investigate
whether the results differed by sex the analyses of central versus
peripheral fractures were replicated for women and men sepa-
rately. Area under the receiver operating characteristic curve
(AUC) analyses were performed to explore which of the bone
phenotypes was the best to discriminate between the patients
with central versus peripheral fractures. Analyses were per-
formed using Stata v15 (version 15; Stata Corporation, Inc., Col-
lege Station, TX, USA).
Results
Patient characteristics according to fracture types
The majority of the patients were women and 59% of the
patients had a fracture of the forearm or ankle (Table 1). Patients
with forearm, ankle, and other fractures were younger than
those with hip fractures (all p < 0.01). BMD at the femoral neck,
total hip, and the site with lowest T-score was higher in patients
with proximal humerus, forearm, ankle, and other types of frac-
tures than those with hip fractures (all p < 0.05). The proportion
of patients with osteoporosis at the femoral neck was highest in
patients with hip fracture (Table 1, Figs. 1 and 2). Mean TBS was
higher in patients with other fractures than those with hip frac-
ture (Table 1). BMD and TBS decreased with age, whereas the
proportion of patients with SQ1–SQ3 fractures increased (Fig. 3).
Patients with central fractures versus peripheral fractures
One in four patients had sustained a central index fracture
(Table 2). Patients with central fractures were older (70.4 versus
64.4 years, p < 0.001) exhibited lower BMD at femoral neck, total
hip, and at the site with lowest T-score (all p < 0.001). Those with
central fractures also had lower mean TBS (1.24 versus 1.28) and
a higher proportion of SQ1–SQ3 fractures (52.0% versus 27.7%),
SQ2–SQ3 fractures (36.8% versus 13.4%), and SQ3 fractures
(21.5% versus 2.2%) than patients with peripheral fractures after
adjustment for sex, BMI, and femoral neck BMD (all p < 0.05).
These differences in femoral neck BMD, TBS, and proportion of
patients with SQ fractures between the central and peripheral
fracture groups remained significant after additional adjustment
for age. Patients with central fractures were older, exhibited
lower BMD at femoral neck and total hip, and a higher propor-
tion of SQ1–SQ3, SQ2–SQ3, and SQ3 fractures than patients with
forearm fractures (Table S1) and patients with forearm or ankle
fractures (Table S2) (all p < 0.01). When patients with vertebral
index fractures were excluded from the analyses, patients with
central fractures were still older (69.9 versus 64.4 years), exhib-
ited lower BMD at femoral neck and total hip, and a higher pro-
portion of SQ3 fractures (12.5% versus 2.2%) than patients with
peripheral fractures (all p < 0.01) (Table S3). However, there
was no difference in TBS or proportion of SQ1–SQ3 and SQ2–
SQ3 fractures between patients with central and peripheral frac-
tures after exclusion of patients with vertebral index fractures. In
sex-stratified analyses, we found the same results in the women
as in the total cohort, except for lower TBS in those with central
versus peripheral fractures after adjustment for age and BMI
(p = 0.003), but not after additional adjustment for femoral neck
BMD (p = 0.066) (data not shown). In men, we found no signifi-
cant difference in femoral neck BMD, TBS, or proportion of
SQ1–SQ3 fractures between those with central versus peripheral
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fractures after adjusting for age and BMI (p > 0.05) (data not
shown).
For discrimination of patients with central versus peripheral
fractures, the AUC for femoral neck BMD, TBS, and SQ1–SQ3 frac-
tures was 0.644, 0.624, and 0.623, respectively. Adding TBS to
femoral neck BMD increased the AUC from 0.644 to 0.663
(p = 0.300). Adding SQ1–SQ3 fractures to femoral neck BMD
increased the AUC to 0.684 (p = 0.002).
Patients with axial fractures versus appendicular fractures
One in 15 patients had an axial index fracture (Table 3). Patients
with axial fractures were older (73.2 versus 65.3 years) and exhib-
ited lower BMD at the femoral neck, total hip, and the site with
lowest T-score after adjustment for age, sex, and BMI (all
p < 0.001). Those with axial fractures also had lower mean TBS
(1.21 versus 1.28) and a higher proportion of SQ1–SQ3 fractures
(82.9% versus 30.2%), SQ2–SQ3 fractures (75.9% versus 15.2%),
and SQ3 fractures (68.3% versus 8.7%) than those with appendic-
ular fractures after adjustment for sex, BMI, and femoral neck
BMD (all p < 0.05). All these differences remained statistically sig-
nificant after additional adjustment for age.
Discussion
In this cohort of subjects with fractures, those with centrally and
axially located fractures exhibited lower BMD, lower TBS, and
exhibited more SQ1–SQ3, SQ2–SQ3, and SQ3 fractures than
those with peripheral and appendicular fractures. These differ-
ences remained significant after adjustment for sex, age, BMI,
and femoral neck BMD, which supports the notion that intrinsic
skeletal properties and localization of fractures are connected.
We propose grouping fragility fractures into central versus
peripheral fractures. This emerges from a clinical observation of
similarities in patients with these types of fractures, which also
is in accordance with the relative proportions of trabecular and
cortical bone at these sites. This grouping is a mélange of exist-
ing classifications of fractures. The group of central fractures
includes both axial and hip/vertebral fractures, in addition to
proximal humeral fractures. The group of peripheral fractures
consists of mainly forearm and ankle fractures, but also other
fractures of the limbs from the diaphysis and distally of the
humerus and femur. Patients with central fractures exhibited
lower BMD including femoral neck, lower TBS, and a higher prev-
alence of vertebral fractures, all associated with increased frac-
ture risk,(15–17) than did patients with peripheral fractures.
Fig. 1. Proportions of patients with osteoporosis at the femoral neck, low
TBS and vertebral fractures (SQ1–SQ3) on vertebral fracture assessment
by type of fracture. TBS = trabecular bone score.
Fig. 2. Proportion and number of patients with osteoporosis, osteopenia, and normal bonemineral density at the femoral neck stratified by types of frac-
ture and in 10-year age groups. Number of patients are shown within each column.
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Although the difference in TBS and SQ1–SQ3 and SQ2–SQ3 frac-
tures was no longer significant after removing patients with ver-
tebral index fractures, the difference in femoral neck BMD and
SQ3 fractures remained. Dividing patients into high-risk and
low-risk groups is meaningful, to identify and prioritize the
patients at highest risk first for post-fracture assessment in this
large volume of patients. These differences were also observed,
and also even more marked, when axial fractures were com-
pared to appendicular fractures. Despite this, division into axial
and appendicular does not seem to be useful for this purpose,
because the group of axial fractures only accounts for 7% of
the patients and lacks serious types of fractures such as hip
and humerus fractures.
The central fractures are sited in the axial and proximal appen-
dicular part of the skeleton, which encompasses a large propor-
tion of trabecular bone, in most areas exceeding 50%. This was
corroborated by our findings of lower TBS in patients with cen-
tral fractures than in patients with peripheral fractures. Mean
TBS, which is a texture index reflecting bone microarchitecture,
has been shown to be lower in patients who have sustained fra-
gility fractures compared to fracture-free controls(18,19) and to be
lower in patients with than without vertebral fractures on
VFA.(10,20) More than one-half of the patients with central frac-
tures in our study had prevalent vertebral fractures on VFA,
almost twice the prevalence in the patients with peripheral frac-
tures. This was obviously enhanced by the group of vertebral
index fractures. After exclusion of the patients with vertebral
fractures, patients with central fractures still exhibited a higher
proportion of SQ3 fractures. VFA provides information on trabec-
ular bone strength, because severity of vertebral compressions
reflect deterioration of trabecular bone microarchitecture.(21)
The patients with central fractures also exhibited lower femoral
neck BMD than those with peripheral fractures. Femoral neck
BMD can be considered as a proxy of cortical bone strength,
because 75% of the bone volume at this site is cortical.(3) Hence,
in patients with central fractures, both trabecular and cortical
bone strength are reduced compared to those with peripheral
fractures. Cortical bone architecture is important for fracture pro-
pensity, as shown in the Tromsø study.(22) A thinner cortex and
increased cortical porosity at the proximal femur were associated
with increased risk of fractures.(23) The importance of coexisting
cortical and trabecular deterioration for fracture propensity has
recently been demonstrated using CT at distal forearm in
women.(24,25) Lower femoral neck BMD, lower TBS, and more
prevalent vertebral fractures on VFA express lower total bone
strength, which in this study is associated with serious fractures
like hip and vertebral fractures, fractures that previously have
been shown to be associated with increased morbidity and
mortality.(26–29)
Prospective studies have shown that low BMD measured at
central,(17) as well as peripheral sites,(30,31) predicts any type of
fracture. TBS predicts major osteoporotic, clinical vertebral and
hip fractures,(19) and vertebral fractures predict new vertebral
and nonvertebral fractures.(5,32) We therefore interpret that
patients with central fractures, who have lower BMD, lower
TBS, and more prevalent vertebral fractures, have a higher risk
of future fractures at all sites, including higher imminent fracture
risk, than patients with peripheral fractures. However, a periph-
eral fracture can be an early sign of bone fragility, and with
advancing age and bone loss, these patients are expected to
have an increased risk of central fractures. Therefore, these
patients are also important to assess to prevent future serious
major fractures, and the attention to peripheral fractures should
not be diminished.
One additional, possible mechanism explaining the differ-
ences observed in this study might be falls. In particular in
Fig. 3. Fitted lines of TBS and femoral neck BMD and prevalence of SQ1–SQ3 fractures on vertebral fracture assessment in relation to age. BMD = bone
mineral density; TBS = trabecular bone score.
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relation to hip fractures, but also other peripheral fractures, falls
have been invoked to explain fractures in subjects with non-
osteoporotic BMD.We found no differences, however, in number
of falls during the last 12 months prior to inclusion between
patients with central and peripheral fractures (Table 2). Hence,
propensity for falls did not influence the type of fracture sus-
tained in this study. We had no detailed information on the
mechanism of the falls, which is a possible limitation. There were
no differences in number of previous fractures, smoking habits,
use of glucocorticoids, or rheumatoid arthritis between the
groups. However, more patients with central fractures reported
that they had parents with a hip fracture than those with periph-
eral fractures. After adjustment for covariates, the remaining dif-
ferences between the patients with central versus peripheral
fractures were the intrinsic skeletal properties, assessed using
BMD, TBS, and VFA.
To our knowledge, this study is the first to classify patients
with fragility fractures into central and peripheral groups. That
these two groups of patients differ is intuitive, but showing this
and quantifying it with data is novel. However, the study has
some limitations. First, only patients in need of a DXA examina-
tion who were healthy enough to undergo follow-up were
invited to this substudy. This resulted in a selection of healthy
patients, with a relatively small proportion of hip fractures. Fur-
ther, some fracture groups were small. We therefore combined
women and men to gain statistical power. The number of men
was small and therefore some of our conclusions may not be
applicable for men. Finally, the study lacks a control group, and
we only measured BMD at central sites. A peripheral measure-
ment could have been of interest to explore whether patients
with peripheral fractures would exhibit lower BMD at a periph-
eral site than patients with central fractures.
In conclusion, patients with fractures at central sites exhibited
lower BMD at the femoral neck, total hip, and the site with lowest
T-score, lower TBS, and higher prevalence of vertebral fractures
on VFA than patients with peripheral fractures. These findings
indicate that bone loss and deterioration of cortical and trabecu-
lar bone structure are important determinants for fractures at
these sites. Hence, patients with central fractures are expected
to have a higher risk of subsequent fractures. All patients with
fragility fractures require secondary fracture assessment, but
we propose that patients with central fractures should get the
highest priority and be assessed first. This does not imply that
the attention to peripheral fractures should be reduced. In recent
years, however, new techniques focusing on trabecular bone
such as TBS and VFA have emerged, but they are less predictive
Table 2. Characteristics of Patients With Central Fractures and Peripheral Fractures
Characteristic Central fractures Peripheral fractures p1 p2 p3
Total patients 152 (24.8) 462 (75.2)
Women 121 (79.6) 374 (81.0) 0.716 0.079 0.408
Age (years) 70.4  8.1 64.4  8.3 <0.001 <0.001 0.001
BMI (kg/m2) 26.0  4.2 26.7  4.0 0.125 0.737 0.787
Prior fracture 62/118 (52.5) 136/359 (37.9) 0.005 0.055 0.384
Smoking 15/121 (12.4) 53/377 (14.1) 0.643 0.616 0.925
Falls in the last year 1.3  0.8 1.3  0.8 0.475 0.405 0.443
Parental hip fracture 30/99 (30.3) 66/319 (20.7) 0.047 0.111 0.029
Glucocorticoid use 7/120 (5.8) 20/385 (5.2) 0.786 0.853 0.896
Rheumatoid arthritis 7/122 (5.7) 14/383 (3.7) 0.316 0.288 0.339
Femoral neck BMD (mg/cm2) 765  118 827  113 <0.001 <0.001 <0.001
Femoral neck BMD T-score −2.0  0.9 −1.5  0.9 <0.001 <0.001 <0.001
Normal 18 (11.8) 105 (22.7)
Osteopenia 95 (62.5) 311 (67.3)
Osteoporosis 39 (25.7) 46 (10.0)
Total hip BMD (mg/cm2) 800  131 876  129 <0.001 <0.001 <0.001
Total hip BMD T-score −1.7  1.0 −1.0  1.1 <0.001 <0.001 <0.001
Lumbar spine BMD (mg/cm2) 1024  180 1062  174 0.022 0.030 0.048
Lumbar spine BMD T-score −1.4  1.5 −1.1  1.4 0.022 0.030 0.051
Lowest BMD T-score all sites −2.3  0.9 −1.9  0.9 <0.001 <0.001 0.001
Normal 11 (7.2) 65 (14.1)
Osteopenia 77 (50.7) 291 (63.0)
Osteoporosis 64 (42.1) 106 (22.9)
Trabecular bone score 1.24  0.10 1.28  0.10 <0.001 0.003 0.034
≥1.31 40 (26.3) 188 (22.7)
1.23–1.31 44 (28.9) 138 (29.9)
≤1.23 68 (44.8) 136 (29.4)
SQ1–SQ3 fractures 79 (52.0) 128 (27.7) <0.001 <0.001 <0.001
SQ2–SQ3 fractures 56 (36.8) 62 (13.4) <0.001 <0.001 <0.001
≥1 SQ3 fracture 32 (21.5) 10 (2.2) <0.001 <0.001 <0.001
Values aremean  SD or n (%). Analysis of agewas not adjusted for age, analysis of sexwas not adjusted for sex, analysis of BMI was not adjusted for BMI,
and analysis of BMD was not adjusted for femoral neck BMD.
BMD = bone mineral density; BMI = body mass index; SQ = semiquantitative score.
1 Unadjusted.
2 Adjusted for sex, BMI, and femoral neck BMD.
3 Adjusted for age, sex, BMI, and femoral neck BMD.
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for peripheral fractures. New modalities focusing on cortical
bone structure, therefore, remain an unmet medical need.
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Table 3. Characteristics of Patients With Axial Fractures and Appendicular Fractures
Characteristic Axial fractures Appendicular fractures p1 p2 p3
Total patients 41 (6.7) 573 (93.3)
Women 32 (78.1) 463 (80.8) 0.666 0.171 0.515
Age (years) 73.2  6.7 65.3  8.5 <0.001 <0.001 <0.001
BMI (kg/m2) 25.7  4.5 26.5  4.0 0.224 0.966 0.990
Prior fracture 17/28 (60.7) 181/449 (40.3) 0.034 0.047 0.445
Smoking 4/31 (12.9) 64/467 (13.7) 0.900 0.901 0.729
Falls in the last year 1.1  0.8 1.3  0.7 0.124 0.099 0.108
Parental hip fracture 7/23 (30.4) 89/395 (22.5) 0.381 0.536 0.303
Glucocorticoid use 3/31 (9.7) 24/474 (5.1) 0.269 0.292 0.306
Rheumatoid arthritis 1/32 (3.1) 20/473 (4.2) 0.893 0.771 0.571
Femoral neck BMD (mg/cm2) 744  116 816  115 <0.001 <0.001 0.030
Femoral neck BMD T-score −2.1  0.8 −1.6  0.8 <0.001 <0.001 0.031
Normal 4 (9.8) 119 (20.8)
Osteopenia 25 (61.0) 381 (66.5)
Osteoporosis 12 (29.2) 73 (12.7)
Total hip BMD (mg/cm2) 775  130 863  131 <0.001 <0.001 0.007
Total hip BMD T-score −1.9  1.0 −1.1  1.0 <0.001 <0.001 0.006
Lumbar spine BMD (mg/cm2) 1007  188 1056  175 0.087 0.095 0.134
Lumbar spine BMD T-score −1.5  1.5 −1.1  1.4 0.079 0.087 0.128
Lowest BMD T-score all sites −2.5  0.9 −1.9  0.9 <0.001 <0.001 0.015
Normal 2 (4.9) 74 (12.9)
Osteopenia 19 (46.3) 349 (60.9)
Osteoporosis 20 (48.8) 150 (20.2)
Trabecular bone score 1.21  0.10 1.28  0.10 <0.001 <0.001 0.040
≥1.31 6 (14.6) 222 (38.7)
1.23–1.31 13 (31.7) 169 (29.5)
≤1.23 22 (53.7) 182 (31.8)
SQ1–SQ3 fractures 34 (82.9) 173 (30.2) <0.001 <0.001 <0.001
SQ2–SQ3 fractures 31 (75.6) 87 (15.2) <0.001 <0.001 <0.001
≥1 SQ3 fracture 21 (51.2) 21 (3.7) <0.001 <0.001 <0.001
Values aremean  SD or n (%). Analysis of agewas not adjusted for age, analysis of sex was not adjusted for sex, analysis of BMI was not adjusted for BMI,
and analysis of BMD was not adjusted for femoral neck BMD.
BMD = bone mineral density; BMI = body mass index; SQ = semiquantitative score.
1 Unadjusted.
2 Adjusted for sex, BMI, and femoral neck BMD.
3 Adjusted for age, sex, BMI, and femoral neck BMD.
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